SMAD2 - SMAD family member 2 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100155304
SMAD2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001256148.1 | NP_001243077.1 | mothers against decapentaplegic homolog 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
mothers against decapentaplegic homolog 2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99720 | Luspatercept | Inhibitor | 98.92% | Unkown |
| HY-P99590A | Sotatercept (mIgG2a) | Inhibitor | 99.93% | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N2037 | Higenamine | 99.31% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99351 | Andecaliximab | Inhibitor | 98.57% | Phase 3 |
Pre-clinical Phase
Bioactive Molecules
(63)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-116084 | Trimethylamine N-oxide | Activator | 98.0% | Unkown |
| HY-126675A | AS2863619 | 98.02% | Unkown | |
| HY-100830 | NCB-0846 | Inhibitor | 99.61% | Unkown |
| HY-108915 | Trimethylamine N-oxide dihydrate | Activator | 99.86% | Unkown |
| HY-116084S | Trimethylamine N-oxide-d9 | Activator | 99.76% | Unkown |
| HY-124447 | BTYNB | 98.0% | Unkown | |
| HY-N6985 | Baccatin III | 99.82% | Unkown | |
| HY-N2037A | Higenamine hydrochloride | 99.34% | Unkown | |
| HY-N6013 | Aloin (mixture of A&B) | 99.36% | Unkown | |
| HY-132187 | Sphingosylphosphorylcholine | 99.50% | Unkown | |
| HY-N3266 | Methyl rosmarinate | 99.89% | Unkown | |
| HY-100448A | Butaprost | 99.85% | Unkown | |
| HY-126675 | AS2863619 free base | 99.87% | Unkown | |
| HY-100444 | SIS3 free base | Inhibitor | 98.02% | Unkown |
| HY-144043 | ALK5-IN-8 | Inhibitor | 98.21% | Unkown |
| HY-P5542 | Vicatertide | Inhibitor | 99.24% | Unkown |
| HY-18766 | EW-7195 | Inhibitor | 98.84% | Unkown |
| HY-122856 | AZ12601011 | Inhibitor | 99.78% | Unkown |
| HY-P10414A | Klotho-derived peptide 1 hydrochloride | Inhibitor | 99.67% | Unkown |
| HY-123900 | AZ12799734 | Inhibitor | 98.67% | Unkown |
| HY-N0363 | (+)-Columbianetin | 99.04% | Unkown | |
| HY-N4107 | Phyllanthin | Inhibitor | 99.97% | Unkown |
| HY-118528A | TP0427736 hydrochloride | Inhibitor | 99.91% | Unkown |
| HY-N0363A | (+)-Columbianetin acetate | 99.83% | Unkown | |
| HY-P10363 | Tiger17 | Activator | 98.47% | Unkown |
| HY-100830A | NCB-0970 | Control | 98.81% | Unkown |
| HY-161398 | TGFβRII-IN-3 | 99.51% | Unkown | |
| HY-171878 | BI-4659 | Inhibitor | 99.78% | Unkown |
| HY-P11223 | CMF9 | Inhibitor | 98.65% | Unkown |
| HY-RS13393 | SMAD2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-117511 | HJC0123 | 99.06% | Unkown | |
| HY-183067 | TAS1440 | / | Unkown | |
| HY-P10359A | TAT-QFNP12 acetate | Inhibitor | 95.90% | Unkown |
| HY-P4890A | Relaxin H3 (human) TFA | / | Unkown | |
| HY-RS17208 | Smad2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-116084S1 | Trimethylamine-N-oxide-13C3 | Activator | / | Unkown |
| HY-10321G | PD173074 (GMP) | Inhibitor | / | Unkown |
| HY-107614G | 1-Oleoyl lysophosphatidic acid sodium (GMP) | Activator | / | Unkown |
| HY-120973 | Butaprost free acid | / | Unkown | |
| HY-126675G | AS2863619 (GMP) | / | Unkown | |
| HY-162404 | (14S,15R)-14-Deoxyoxacyclododecindione | Inhibitor | / | Unkown |
| HY-162405 | STAT6-IN-12 | Inhibitor | / | Unkown |
| HY-168607 | ALK5-IN-83 | Inhibitor | / | Unkown |
| HY-170578 | SIRT2-IN-17 | Inhibitor | / | Unkown |
| HY-172108 | TGFβRI-IN-7 | Inhibitor | / | Unkown |
| HY-181430 | PXS 25 | Inhibitor | / | Unkown |
| HY-181431 | PXS 64 | Inducer | / | Unkown |
| HY-183067A | TAS1440 benzoate | / | Unkown | |
| HY-P10359 | TAT-QFNP12 | Inhibitor | / | Unkown |
| HY-P10414 | Klotho-derived peptide 1 | Inhibitor | / | Unkown |
| HY-P11827 | C11 peptide-1 | Inhibitor | / | Unkown |
| HY-P4890 | Relaxin H3 (human) | / | Unkown | |
| HY-W108953 | Myristoyl tetrapeptide-12 | Activator | / | Unkown |
| HY-W722562 | Trimethylamine oxide-15N | 99.93% | Unkown | |
| HY-Y1269D | Ammonium chloride, for molecular biology | / | Unkown | |
| HY-118528 | TP0427736 | Inhibitor | / | Unkown |
| HY-12273G | DMH-1 (GMP) | Inhibitor | / | Unkown |
| HY-124595 | MPT0B098 | Inhibitor | / | Unkown |
| HY-N0363AR | (+)-Columbianetin acetate (Standard) | / | Unkown | |
| HY-N0363R | (+)-Columbianetin (Standard) | / | Unkown | |
| HY-N2037AS1 | Higenamine-d4-1 hydrochloride | / | Unkown | |
| HY-N6013R | Aloin (mixture of A&B) (Standard) | / | Unkown | |
| HY-RS23660 | Smad2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99720A | Luspatercept (mIgG2a) | Inhibitor | 99.9% | Unkown |
| HY-P992410 | MEDI-579 | Inhibitor | / | Unkown |
| HY-P992108 | Efadirelaxin alfa | Activator | / | Unkown |